News

Grants now available for Medical Technology in Leicester and Leicestershire

Medical technology businesses in Leicester and Leicestershire can apply to cover 50% of their clinical evaluation costs, thanks to a project delivered by Medilink East Midlands and part-funded by the European Regional Development Fund (ERDF) and the East Midlands Academic Health Science Network (EMAHSN). Grants are available to qualifying companies …

Read More »

SurePulse VS achieves CE approval

SurePulse Medical Ltd are delighted to announce that the SurePulse VS has now received CE approval. SurePulse VS represents a significant advance for babies, parents and clinicians in providing important and timely information to provide optimal care for newborn babies. Amazingly, approximately 10% of newborns (80,000/yr in the UK, 14 …

Read More »

Medilink East Midlands welcomes its 21st Patron

The University of Derby has been recognised for the contribution it makes to life sciences, by becoming the 21st Patron of Medilink East Midlands (EM). Medilink EM works with life science businesses, academic institutions and the NHS across the East Midlands, to help new and existing life science companies to …

Read More »

Collated Guidance for Business on no deal preparations

In the event of not reaching a deal with the European Union by March 29, 2019, Government has published the following guidance for businesses: Update on continuity of supply and border assumptions New border assumptions show that there will be significantly reduced access cross the short straits to and from …

Read More »

AdamsonJones adds to Leicester and Nottingham teams

AdamsonJones, the growing East-Midlands based firm of intellectual property (IP) specialists has recently welcomed two new recruits to its Leicester and Nottingham teams. Peter Banks joins the firm’s Leicester office to train as a patent attorney, working mainly with mechanical, materials and electrical technologies. Peter already has several years’ experience …

Read More »

MHRA Inspection success for Nottingham’s Upperton Pharma Solutions

Upperton Pharma Solutions’ new pharmaceutical spray drying manufacturing facilities at Nottingham Science and Technology Park have successfully passed inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA). A pharmaceutical spray drying contract development and manufacturing organisation (CDMO), Upperton Pharma Solutions moved to its new facilities on Nottingham Science …

Read More »

Medilink East Midlands will continue to inspire life science companies in Derbyshire and Nottinghamshire

Life science companies in Derbyshire and Nottinghamshire can become ‘inspired’ with their business operations, thanks to a project delivered by Medilink East Midlands and part-funded by the European Regional Development Fund (ERDF). Inspiring Networking to Stimulate Technology Innovation in Life Sciences (INSTILS) is a £7.39million scheme, part-funded by ERDF, to …

Read More »

ABHI’s US Accelerator set to target Tennessee

Following the success of ABHI’s work in Texas, which has seen a host of companies forge new business relationships and research partnerships, the US Accelerator programme will now target the State of Tennessee. Taking place from 24th – 29th March 2019, the mission is part of the ABHI’s broader engagement …

Read More »

Texas proves the gateway to stateside success for UK HealthTech

Clinical trials, research collaborations, new partnerships and sales are all outcomes from the Association of British HealthTech Industries (ABHI) work in Texas. Last week, a cohort of British HealthTech companies and medical institutions took part in the tenth mission to the State to showcase medical devices, diagnostic software and digitally-enabled …

Read More »

No Deal Update from the Office of Life Sciences

The Secretary of State for Health and Social Care, Matt Hancock, has this week written to suppliers of medicines, medical devices and clinical consumables with a progress update on the Government’s contingency planning approach. This includes an update on changes to cross-Government planning assumptions about potential border delays, should the …

Read More »

Quotient Sciences Constructs State-of-the-Art Early-Phase Formulation and Manufacturing Facility in U.S.

Quotient Sciences, a leading drug development services organisation, announces a significant expansion to its operations in the U.S. with the opening of a state-of-the-art, 45,000-square-foot facility located near Philadelphia, in Garnet Valley, Pa. The $15 million investment will create a center of excellence for early-phase formulation development and clinical trial …

Read More »